Efficacy and safety of HAIC combined with tyrosine kinase inhibitors versus HAIC monotherapy for advanced hepatocellular carcinoma: a multicenter propensity score matching analysis

• Κύριοι συγγραφείς: Miaomiao Yang (Συγγραφέας), Xiongying Jiang (Συγγραφέας), Huan Liu (Συγγραφέας), Qingyu Zhang (Συγγραφέας), Jing Li (Συγγραφέας), Li Shao (Συγγραφέας), Lei Zhao (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

PurposeThis study aimed to assess the clinical efficacy and safety of the combined approach involving hepatic arterial infusion chemotherapy (HAIC) and tyrosine kinase inhibitors (TKIs) for the treatment of advanced hepatocellular carcinoma (HCC).Patients and methodsIn this multicenter retrospective...